The Acidic Domain of the Human Cytomegalovirus UL37 Immediate Early Glycoprotein Is Dispensable for Its Transactivating Activity and Localization but Is Not for Its Synergism  by Zhang, Huizhen et al.
VIROLOGY 223, 292–302 (1996)
ARTICLE NO. 0481
The Acidic Domain of the Human Cytomegalovirus UL37 Immediate Early Glycoprotein Is
Dispensable for Its Transactivating Activity and Localization but Is Not for Its Synergism
HUIZHEN ZHANG, HEBAH O. AL-BARAZI, and ANAMARIS M. COLBERG-POLEY1
Center for Virology, Immunology and Infectious Disease Research, Children’s National Medical Center,
111 Michigan Avenue N.W., Washington DC 20010
Received April 4, 1996; accepted July 2, 1996
The product of the human cytomegalovirus (HCMV) immediate early (IE) UL37 gene, gpUL37, is predicted to be a type I
membrane-bound glycoprotein. Typically for HCMV IE proteins, gpUL37 transactivates nuclear gene expression and acts
synergistically with other IE proteins. We have initiated mutational analysis of the gpUL37 domains to determine which are
required for its transactivating activity. The acidic domain, a feature notably required for the activity of many nuclear
transcription factors, was deleted from gpUL37. Similar to wild-type gpUL37, the mutant retained a dose responsive transacti-
vating activity in transiently transfected HeLa cells. Transactivating activity of the mutant was also observed in permissive
human diploid fibroblasts when it was cotransfected with IE1. However, the gpUL37 acidic domain mutant is defective for
synergism with another HCMV IE protein, pUS3. We found that wild-type gpUL37 and its acidic domain mutant (Daa53-
140) are nonnuclear proteins and are indistinguishable in localization. Confocal microscopy of human cell types coexpressing
both HCMV IE regulatory proteins, IE1 and gpUL37, showed gpUL37 does not colocalize with the IE1 nuclear protein. Taken
together, our results establish that gpUL37 is a nonnuclear protein that requires its acidic domain for synergism with pUS3
but not for its transactivating activity or its localization. q 1996 Academic Press, Inc.
INTRODUCTION regulated (Tenney and Colberg-Poley, 1991a,b). UL37
RNA is expressed predominantly during IE times of infec-
Human cytomegalovirus (HCMV), a medically signifi-
tion, is rapidly transported to the cytoplasm, and is asso-
cant herpesvirus, is the leading viral cause of birth de-
ciated to polysomes indicating no apparent posttran-
fects and a major cause of fatal pneumonitis in bone
scriptional regulation at the level of nuclear retention or
marrow transplant patients (Britt and Alford, 1996). De-
exclusion from polysome binding (Kouzarides et al., 1988;spite its medical importance, the role of viral proteins
Tenney and Colberg-Poley, 1991a,b). Thus, upon tran-and the requirement for their function during viral growth
scription, processing, and transport, UL37 RNA becomesare just being elucidated. The immediate early (IE) genes,
available for translation in the cytoplasm.located in five noncontiguous regions of the HCMV ge-
The UL37 product, gpUL37, is predicted to be typenome, are transcribed first following viral entry and trans-
I membrane-bound protein as are the products of thelocation to the nucleus (reviewed in Mocarski, 1996).
unspliced US3 IE RNA and of the UL119-115 IE RNAMultiple transcripts are produced at IE, early, and late
(Weston, 1988; Kouzarides et al., 1988; Chee et al., 1990;times of infection from the major IE (MIE), UL36-38,
Leatham et al., 1991). In contrast, the well-studied prod-UL115-119, IRS1/TRS1, and US3 loci by the use of alter-
ucts of the HCMV MIE locus, IE1 and IE2, are nuclearnative promoters, splicing, and polyadenylation signals
proteins which bind directly to DNA and interact with(Kouzarides et al., 1988; Weston, 1988; Stenberg et al.,
transcription factors (LaFemina et al., 1989; Pizzorno et1989; Leatham et al., 1991; Tenney et al., 1993; Rawlinson
al., 1991; Hagemeier et al., 1992; Chiou et al., 1993; Fur-and Barrell, 1993; reviewed in Mocarski, 1996; Colberg-
nari et al., 1993; Jupp et al., 1993; Klucher et al., 1993;Poley, 1996). Consequently, IE transcripts encode pro-
Lang and Stamminger, 1993; Arlt et al., 1994; Lukac etteins which have unique as well as common domains.
al., 1994).IE proteins are regulatory proteins that alter the expres-
Although it does not encode the predominant IE pro-sion of cellular or viral genes (reviewed in Mocarski,
teins during HCMV growth, the likely importance of the1996; Colberg-Poley, 1996).
UL36-38 IE locus for HCMV biology has been suggestedRNA expression of the UL37 IE gene is very stringently
by a number of recent findings. First, its IE products have
known nuclear regulatory activity (Colberg-Poley et al.,
1 To whom correspondence and reprint requests should be ad- 1991, 1992). Second, Anders and his co-workers estab-dressed at Center I Research, Room 5720, Children’s National Medical
lished that the UL36-38 locus is required for HCMV DNACenter, 111 Michigan Avenue, N.W., Washington DC 20010. Fax: 202-
884-3985. E-mail: colberam@gwis2.circ.gwu.edu. replication (Pari et al., 1993) and encodes a transactivator
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of HCMV DNA replication gene promoters (Iskenderian gpUL37 lacking the acidic domain was derived from p414
by cleavage with AgeI (at nucleotide (nt) 52551 and ntet al., 1996). Most significantly, oligonucleotides against
UL36 and UL37 RNAs inhibit HCMV DNA replication and 52287) and self-ligation of the larger fragment following
its purification from low-melting-temperature agarose us-growth in permissive human diploid fibroblasts (Smith
and Pari, 1995; Pari et al., 1995). Finally, motifs of the ing Elutip-D columns (Schleicher & Schuell). Nucleotide
sequencing using the U.S. Biochemical Sequenase kitUL36, UL37, and UL38 proteins, rather than the primary
DNA sequence itself, are conserved in open reading verified the identity of the mutant. For IVT/T, the mutant
cDNA insert from p521 was subcloned as an EcoRI frag-frames (ORF) of the human betaherpesvirus herpesvirus
6 (HHV-6) genome (Nicholas and Martin, 1994; Gompels ment into the pCITE vector generating p588.
et al., 1995). Proteins encoded by the conserved region
Other plasmid DNA constructionsof the HHV-6 genome have known regulatory activity
(Nicholas and Martin, 1994). The hsp70 promoter – chloramphenicol acetyltransfer-
ase (CAT) construction used, pHBCAT, was provided byThe ability of the gpUL37 to transactivate nuclear gene
expression was demonstrated by its activation of the Dr. R. Morimoto (Wu et al., 1985). IE1 was expressed
from the genomic construction, pRR59 (Colberg-Poley ethuman heat shock protein 70 (hsp70) promoter (Colberg-
Poley et al., 1992; Tenney et al., 1993). Expression of al., 1991, 1992). We used an expression clone of the US3
unspliced cDNA to produce wt pUS3 (Tenney et al., 1993).the hsp70 gene is normally increased during permissive
infection with HCMV and requires IE gene expression The vector (p394) containing the MIE promoter and SV40
polyadenylation signal and the glycoprotein B (gB) ex-(Colberg-Poley and Santomenna, 1988; Santomenna and
Colberg-Poley, 1990). This stimulation appears to have pression vector (p370) have been described (Colberg-
Poley et al., 1992). When specified, pCH110 (Pharmacia),biological consequences as heat shock treatment of hu-
man cells increases HCMV early gene expression (Zer- containing the SV40 early promoter driving the indicator
lacZ gene, was used as an internal control.bini et al., 1986). Analogously to the products of the MIE
locus, IE1 and IE2, gpUL37 can act additively or synergis-
Enzymatic and protein analysestically with other IE proteins in nuclear transactivation of
the hsp70 promoter construction (Colberg-Poley et al., CAT assays were performed as previously described
(Colberg-Poley et al., 1992). Briefly, transfected cells were1992; Tenney et al., 1993).
The purpose of the present studies is to determine incubated for 48 hr, harvested by washing twice with
11 phosphate-buffered saline (PBS), and resuspendedwhether the acidic domain, a motif known to be required
for several nuclear regulatory proteins including the in 0.25 M Tris, pH 8.0. The cells were lysed by freezing
and thawing thrice and the protein concentration of eachHCMV IE2 protein (Ma and Ptashne, 1987; Sadowski et
al., 1988; Triezenberg et al., 1988; Pizzorno et al., 1991; lysate was determined using the Bio-Rad Protein Deter-
mination kit. CAT assays were performed using 5 – 100Tjian and Maniatis, 1994), is necessary for the known
activities of gpUL37 or its location. We found that the mg of protein. The conversion of 14C-chloramphenicol to
its acetylated forms was quantified by scintillation count-acidic domain is not required for gpUL37 localization
or transactivation of the hsp70 construction but is for ing of the reaction products previously resolved by thin-
layer chromatography using a chloroform:methanol (95:5)synergism with pUS3.
solvent system and detected by autoradiography. b-Ga-
lactosidase was measured by conversion of chlorophe-MATERIALS AND METHODS
nol red –b-D-galactopyranoside (Boehringer-Mannheim)
Transfection of human cells to chlorophenol red (Eustice et al., 1991).
Nonpermissive HeLa cells and permissive human dip- IVT/T
loid fibroblasts (HFF) were transfected using calcium
UL37 wt and mutant proteins were synthesized by ad-phosphate coprecipitation or DEAE dextran, respectively,
dition of the corresponding DNAs to the Single Tubeas previously described (Colberg-Poley et al., 1992).
Protein System 2 (Novagen) as recommended by the
manufacturer. Synthesized proteins were labeled with L-Wild-type (wt) UL37 and the acidic domain mutant
[35S]methionine (translation grade, New England Nu-DNA construction
clear) and resolved by electrophoresis in 10% sodium
dodecyl sulfate – polyacrylamide gels (Laemmeli, 1970).Wt gpUL37 was expressed from p414 containing the
UL37 cDNA from which the UL37 ORF has been removed Molecular mass standards (Sigma Chemical Co.) were
used to determine apparent molecular mass.(Colberg-Poley et al., 1992). For in vitro transcription and
translation (IVT/T), the wt UL37 cDNA contained in p414
gpUL37 antiserumwas subcloned as an EcoRI fragment into the pCITE
vector (Novagen), generating p591. Polyclonal immune serum (Ab1601, Fig. 1) was pre-
pared by repeated immunization of a rabbit with a cou-An expression clone (p521) which encodes mutant
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pled synthetic peptide (DEGSSSTKNDVHRIV, amino constructed a gpUL37 mutant lacking aa53-140 and, con-
sequently, its acidic domain. The primary translationacids (aa) 473 – 487) from the carboxy terminus of the
UL37 ORF (Kouzarides et al., 1988; Chee et al., 1990). product of the acidic domain mutant ORF is predicted to
be 46 kDa.The peptide was coupled to keyhole limpet hemocyanin
prior to injection into a rabbit. Rabbit immune serum was
Production of gpUL37 acidic domain mutant proteinproduced by Hazelton Laboratories (Denver, PA). The
in vitrocorresponding preimmune serum, at the same dilution,
was used as control for the specificity of the immune
Sequence analysis of the mutant DNA verified its identity.
serum.
We demonstrated the ability of the mutant DNA to encode
the predicted mutant gpUL37 using IVT/T (Fig. 2). WtOther antibodies
gpUL37 migrated as an apparent 60-kDa protein, slightly
Mouse monoclonal antibody against gB (CH-28) was larger than its predicted molecular mass of 56 kDa (lane
obtained from Dr. Lenore Pereira (UCSF, Pereira et al., 1). The primary translation product of the acidic domain
1982). Mouse monoclonal antibody against IE1 (MAB810) construction (Daa53-140) migrated at an apparent molecu-
was purchased from Chemicon Corporation. lar mass of 43 kDa (lane 2). This observed mass is slightly
smaller than its predicted mass of 46 kDa (Fig. 1) and is,
Indirect immunofluorescence (IFA) as predicted, smaller than that of wt gpUL37 (Fig. 2). The
production of the correct mutant ORF was confirmed by itsFixed cells were washed with PBS and stained with
specific immunoprecipitation using rabbit polyvalent anti-the primary antibody diluted in 10% BSA for 1 hr at 377.
bodies against the amino and carboxy termini of gpUL37The cells were washed thrice with PBS containing 1%
(data not shown) and by the specific reactivity in IFA ofTriton X-100 for 5 min each and then stained for 1 hr at
rabbit polyvalent serum against the carboxy terminus of the377 with secondary antibodies (Leinco Tech), either IgG
UL37 ORF (see below).or Fab fragments, labeled with either fluorescein isothio-
cyanate (FITC) or Texas red and diluted in 10% BSA. The
gpUL37 location in transfected HFF cells and in
slides were finally washed thrice with PBS containing
transfected HeLa cells0.2% Tween 20, once with water, and air dried. The slides
were mounted with coverslips using 1:1 PBS:glycerol so- HFF cells transfected with an gpUL37 expression vector
lution. Optical analysis was performed using a Bio-Rad showed specific nonnuclear staining with Ab1601 (Fig. 3a).
MRC1000 confocal laser scanning imaging system and As a control for nonspecific staining, HFF cells were trans-
recorded using a Mitsubishi CP2000 printer (Center for fected with an expression vector of gB. The cells expressing
Microscopy and Image Analysis, George Washington gB showed no specific staining with the anti-gpUL37
University). Ab1601 (data not shown). The production of gpUL37 was
also detected in HeLa cells transfected with the gpUL37
Statistical analysis expression vector (Fig. 3b). Although HeLa cells are nonper-
missive for HCMV infection and do not express the IEThe similarity of the mutant gpUL37 to wt gpUL37 or
genes following infection, transfected HCMV IE genes areto control vector or gB for transactivation or for synergism
expressed suggesting a block in viral entry (Tsutsui andwas measured by classical analysis of variance tech-
Nogami-Satake, 1990). Similar to the pattern observed inniques (ANOVA, Zar, 1984).
HFF cells, gpUL37 produced in nonpermissive HeLa cells
was predominantly detected in nonnuclear compartmentsRESULTS
of the cells. Control HeLa cells, transfected with an expres-
sion vector of gB, did not stain with Ab1601 (data notThe features of the UL37 ORF which suggest that
gpUL37 is a type I membrane-bound protein (Kouzarides shown). To demonstrate the production and location of the
gpUL37 acidic domain mutant, HeLa cells were transfectedet al., 1988; Chee et al., 1990) as well as other notable
features are schematically represented in Fig. 1. gpUL37 with mutant DNA and subsequently stained with Ab1601
(Fig. 3c). The staining pattern observed with cells express-has hydrophobic leader (aa1-22) and transmembrane
(TM, aa433-459) sequences, as well as an acidic domain ing the acidic domain mutant is indistinguishable from the
pattern obtained with wt gpUL37 (Fig. 3b). Thus, transfected(aa81-108), 17 potential N-linked glycosylation sites
(throughout aa206-391), a basic domain (aa368-382), and human cells produced optically detectable amounts of wt
gpUL37 and mutant gpUL37. The conditions for detectiona presumptive cytoplasmic tail (aa460-487). gpUL37 con-
tains 13 Cys residues, 3 of which (aa291, 366, and 453) of both the mutant gpUL37 and the wild-type gpUL37 by
confocal microscopy are identical. As the intensity of stain-are conserved in the HHV-6 homologue (Nicholas and
Martin, 1994; Gompels et al., 1995). If its signal sequence ing was similar for both proteins under these conditions,
the levels of expression of both are comparable. Moreover,is retained, the primary translation wt UL37 product is
predicted to be a 56-kDa protein. For these studies, we the frequency of cells positive for either protein and the
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FIG. 1. Epitope used for Ab1601 production and domains contained in the acidic domain mutant. Wt gpUL37 is represented on the top of the
figure with its hydrophobic leader and TM domains (coils), putative N-glycosylation sites (branches), and acidic and basic domains (filled boxes).
The peptide (aa473-487) used to generate rabbit polyclonal antiserum (Ab1601) is indicated. The domains in the acidic domain mutant protein are
represented below those in wt gpUL37. wt gpUL37 has a predicted molecular mass of 56 kDa, whereas the acidic domain mutant lacks aa53 to
140, inclusive, and has a predicted molecular mass of 46 kDa.
pattern of localization were similar for both. In all of these efficiently and express the transfected genes abundantly
(Figs. 3b and 3c). Wt gpUL37 alone induced the expres-cases, the protein was found to be a nonnuclear protein
consistent with the predicted UL37 ORF. sion of the hsp70 promoter – CAT construction about 8.2
{ 2.8-fold above vector DNA alone (Fig. 4). The gpUL37
acidic domain mutant (Daa53-140) retained about 90%Transactivating activity of wt and of the acidic domain
of the wt transactivating activity (7.4 { 1.5-fold) abovemutant gpUL37 in HeLa cells
vector DNA alone. The values shown are an average of
To determine whether the acidic domain is required six samples (duplicates from three independent experi-
for gpUL37 transactivating activity, we assayed the ability ments). Multiple comparisons of hsp70– CAT transactiva-
of the acidic domain mutant to transactivate hsp70 ex- tion levels by gpUL37 expression vectors with and with-
pression following transient transfection of nonpermis- out standardization to an internal control, pCH110,
sive HeLa cells (Fig. 4). HeLa cells can be transfected showed that the internally standardized values vary less
than 1.02- to 1.5-fold from the values shown. The internal
control plasmid, pCH110, contains the SV40 early pro-
moter driving the indicator lacZ gene and is minimally
responsive to transactivation by gpUL37. The transacti-
vating activity of the wt and of the mutant gpUL37 did
not differ statistically (P 0.05) as determined by ANOVA
analysis. Thus, the acidic domain of gpUL37 is dispens-
able for its nuclear regulatory activity. Cells transfected
with an expression clone of the HCMV structural glyco-
protein, gB, produced CAT activities (1.1 { 0.3-fold) simi-
lar to those from negative control cultures transfected
with vector DNA (1.0{ 0.2-fold). Although gB and gpUL37
share some analogous features such as hydrophobic
leader and TM domains as well as multiple N-glycosyla-
tion sites, gB has no known regulatory activity and thus
served as a negative control for our transactivation exper-
iments. ANOVA analyses revealed that hsp70 transacti-
vation levels in either gB- or vector DNA-transfected cells
FIG. 2. Production of wt and mutant gpUL37 using IVT/T. Wt and were statistically different from those in cells transfected
mutant gpUL37 proteins were produced by addition of plasmid DNAs with either wt or mutant gpUL37 (P  0.01).to the Single Tube Protein System 2 (Novagen) and were labeled with
L-[35S]methionine. Proteins synthesized in unprogrammed lysates (lane
Hsp70 transactivation is dose responsive3), in lysates directed by p591 (lane 1, wt), or by p588 (lane 2, Daa53-
140, acidic domain mutant) DNA were resolved on 10% SDS – PAGE
To determine whether hsp70 transactivation is doseand visualized by fluorography. All lanes are taken from a single gel
responsive, we performed a titration experiment on wtand were exposed for the same length of time. In vitro synthesized
proteins are indicated by the arrowheads. and mutant gpUL37 DNAs (Fig. 5). HeLa cells were trans-
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FIG. 3. gpUL37 production in transfected permissive HFF cells (a) and HeLa cells (b, c). HFF cells and HeLa cells were transfected with 10 mg
of p414 (gpUL37, a and b) or of p521 (acidic domain mutant, c) DNA. The transfected cells were incubated for 48 hr, fixed, and stained with Ab1601
(1:100) followed by fluorescein isothiocyanate-labeled goat anti-rabbit IgG (1:100) and examined by confocal microscopy. Control cultures transfected
with p370 (gB) showed no staining with Ab1601 (data not shown). The scale of the confocal images is indicated by the bar.
fected with different amounts of each construction. In- tion by the acidic domain mutant (3.5 { 0.2) was signifi-
creasing hsp70 transactivation (up to 8.6 { 0.7-fold) was cantly above (P  0.01) the vector control (1.0 { 0.06).
observed upon transfection with increasing amounts of At 10 mg of transfected DNA, similar results were ob-
wt UL37 DNA encoding wt gpUL37. Similarly, increasing tained; that is, hsp70 transactivation by the acidic domain
hsp70 transactivation was also observed with increasing mutant (3.5 { 0.2-fold) was significantly lower (P 0.025)
amounts of transfected DNA which encodes gpUL37 than the wt level (7.0 { 0.03). Nevertheless, the acidic
acidic domain mutant. At 2.5 mg of transfected DNA, the domain mutant still showed, in this experiment, regula-
acidic domain mutant (3.5 { 0.2) transactivated the hsp70 tory activity which is significantly above (P  0.025) the
promoter construction significantly less (P  0.025) than negative control, vector (1.0 { 0.2). These results verified
wt gpUL37 (5.9 { 0.2). Nonetheless, hsp70 transactiva-
FIG. 4. Hsp70 transactivation by gpUL37 acidic domain mutant. HeLa FIG. 5. Dose responsive hsp70 transactivation. HeLa cells were
transfected in duplicate with pHB– CAT (10 mg) and with 1, 2.5, 5, orcells were transfected with the indicated DNAs (5 mg each) and pHB-
CAT DNA (10 mg). Transfected cells were incubated for 48 hr, harvested, 10 mg of wild-type (filled squares), Daa53-140 mutant (filled triangles),
or vector (open squares) DNA. Cells were incubated for 48 hr, har-and assayed for CAT activity. The average conversion of chlorampheni-
col to its acetylated forms was determined for each group and standard- vested, and assayed for CAT activity. The average conversion of chlor-
amphenicol to its acetylated forms was determined for each group asized on the average control value obtained with cells transfected with
vector (p394) DNA. The average of six samples (duplicates from three in Fig. 4. The averages of duplicate samples are shown. The standard
error for every point is £0.7.independent experiments) for each group is shown.
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the dose responsiveness of hsp70 by wt and mutant
expression vectors and the dispensability of the acidic
domain sequences for gpUL37 nuclear regulatory activity
under various transfection conditions.
Regulation of hsp70 expression by wt and by the
acidic domain mutant in permissive HFF cells
To determine if wt gpUL37 and the acidic domain mu-
tant had nuclear regulatory activity in permissive cells,
HFF cells were transfected with DNAs encoding IE1 and/
or gpUL37 (Fig. 6A). We had previously found that pooled
UL36-38 cDNAs and an IE1 expression clone cotrans-
fected into HFF cells transactivated an hsp70 promoter
construction (Colberg-Poley et al., 1991, 1992). To deter-
mine whether gpUL37 was, at least in part, responsible
for the hsp70 transactivation observed, we transfected
HFF cells with the UL37 cDNA encoding wt gpUL37 in
presence of the IE1 expression clone. Wt gpUL37 in-
creased the expression of the hsp70 promoter – indicator
construction 3.3 { 0.9-fold above the levels in HFF cells
transfected with IE1 in presence of the negative control,
the gene encoding the structural glycoprotein, gB (1.0 {
0.1-fold). The acidic domain (Daa53-140) mutant (6.1 {
2.6-fold) appeared to be more efficient than the wt
gpUL37 in hsp70 transactivation. However, this differ-
ence was not statistically significant (P  0.05). These
results demonstrate the ability of wt gpUL37 and of the
gpUL37 acidic domain mutant, in the presence of IE1, to
regulate nuclear gene expression in permissive HFF
cells. The general pattern of hsp70 promoter response
to the wt and mutant gpUL37 in the presence of IE1 was
similar to that obtained in HeLa cells transfected with wt
and mutant alone (Figs. 4 and 5).
Because the known nuclear regulatory activity of
gpUL37 is best characterized in HeLa cells, we examined
hsp70 transactivation by the mutant, in the presence of
IE1, in HeLa cells (Fig. 6B). The pattern of transactivation
FIG. 6. Hsp70 regulation by IE1 and gpUL37 in (A) permissive HFFby the acidic domain mutant, in the presence of IE1, in
cells and in (B) nonpermissive HeLa cells. (A) HFF cells were trans-HeLa cells (Fig. 6B) was strikingly similar to that obtained
fected with 10 mg of pHB –CAT and 2.5 mg each of expression vectorsin the permissive HFF cells (Fig. 6A). That is, transactiva- for IE1 (pRR59) and 2.5 mg each of wt gpUL37 (p414), acidic domain
tion by wt gpUL37 (2.6 { 0.4-fold) and by the acidic mutant Daa53-140 (p521), or gB (p370) DNAs. (B) HeLa cells were
domain (Daa53-140) mutant (5.6 { 0.2-fold), in the pres- transfected with pHBCAT (10 mg) and IE1 (5 mg) and the indicated
DNAs (5 mg). The average conversion of chloramphenicol to its ace-ence of IE1, increased the expression of the hsp70 con-
tylated forms was determined for each group and standardized to con-struction above the level of IE1 cotransfected with gB
trol values obtained with cells transfected with IE1 and p370 DNA. The(1.0 { 0.3-fold). In this case, the activity of the acidic
mean values for each group were determined using data from two
domain mutant, in the presence of IE1, was significantly experiments, each with duplicate samples (A), or using duplicate sam-
higher than the wt gpUL37 (P  0.05). Thus, both wt ples (B).
gpUL37 and the acidic domain mutant of gpUL37
(Daa53-140) have demonstrable regulatory activities in
both permissive HFF and nonpermissive HeLa cells. vectors of gpUL37 and IE1 and stained for both antigens
using Ab1601 and MAB810, which reacts with a domainAs gpUL37 and IE1 are regulatory proteins and act
additively in hsp70 transactivation, we compared the lo- encoded by IE1 exon 3 sequences. The stained cells
were optically dissected using confocal microscopy.cation of these two IE proteins in transfected HFF cells
(Figs. 7a – 7c) and in transfected HeLa cells (Figs. 7d – 7f). gpUL37 localized to the perinuclear area of the HFF cell
(Fig. 7a). In contrast, the MIE protein, IE1, produced fol-HFF cells or HeLa cells were transfected with expression
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FIG. 7. gpUL37 and IE1 localize to different subcellular compartments in transfected HFF cells (a –c) and in transfected HeLa cells (d– f). Cells
were stained with Ab1601 (1:100), then with Ab1601 (1:100) and MAB810 (1:200), followed by secondary Ab against rabbit (FITC-anti rabbit IgG,
1:100) and against mouse (Texas red-anti mouse IgG, 1:100). The stained cells were analyzed by confocal microscopy for FITC (a, d) and for Texas
red (b, e) simultaneously. The resulting images were overlapped with both signals (c, f). The scale of the confocal images is indicated by the bar.
lowing transfection, localized within the nucleus of HFF plasm. The results also demonstrate that coexpression
of IE1 and gpUL37 does not alter the location of eithercells as indicated by the red signal (Fig. 7b). No colocal-
ization of the IE1 and gpUL37 IE proteins was detectable HCMV IE protein.
by image overlap (Fig. 7c). Since the efficiency of trans-
fection of HFF cells is low, only one representative HFF Deletion of the acidic domain of gpUL37 abolishes
cell is seen on average in a field. Nevertheless, multiple synergism with pUS3
HFF cells expressing UL37 and IE1 were seen in different
fields. They all showed patterns of staining for gpUL37 We previously found that gpUL37 could act synergisti-
cally with the HCMV IE protein pUS3 in hsp70 transacti-and for IE1 similar to those shown. Analogous results
were obtained in transfected HeLa cells; that is, gpUL37 vation (Colberg-Poley et al., 1992; Tenney et al., 1993).
To determine whether the acidic domain of the proteinlocalized to the perinuclear area of the cell (Fig. 7d), IE1
localized within the nucleus (Fig. 7e), and colocalization is dispensable for synergism with pUS3, we assayed the
acidic domain mutant for hsp70 transactivation in theof the IE1 and gpUL37 IE proteins was not detectable by
image overlap (Fig. 7f). Examination of nine optical presence of pUS3 (Fig. 8). Consistent with our previous
findings, wt gpUL37, in the presence of pUS3, increasedplanes of the transfected HeLa cells showed no colocal-
ization of IE1 and gpUL37 on any of those planes exam- the expression of the hsp70 construction synergistically
(27.4{ 13.3-fold) above the level of cells transfected withined (data not shown). These results suggest that
gpUL37 does not colocalize to the same subcellular com- vector DNA (p394) alone (1.0 { 0.1-fold). Cells trans-
fected with vector DNA and wt US3 increased hsp70partment as IE1; that is, gpUL37 is predominantly perinu-
clear and is not optically detectable within the nucleo- expression about 6.2 { 2.4-fold above that observed in
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verifies the UL37 ORF (Kouzarides et al., 1988; Chee et
al., 1990). Consistent with its proposed structure is the
finding that gpUL37 does not colocalize with nuclear IE1,
another HCMV IE regulatory protein. Rather, we have
found, in other studies, that gpUL37 is a membrane-
bound, N-glycosylated protein and that it traffics through
the endoplasmic reticulum (ER) and Golgi apparatus (Al-
Barazi and Colberg-Poley, in press).
In spite of its location, gpUL37 transactivates nuclear
gene expression in permissive and nonpermissive hu-
man cells. In fact, the regulatory activities of wt and mu-
tant gpUL37 are surprisingly similar in permissive HFF
cells and in nonpermissive HeLa cells. Therefore, there
are no obvious host cell-specific differences in the nu-
clear regulatory activities of wt gpUL37 and its mutant
resulting from the cell type transfected. Spector and her
co-workers also found similar IE2 regulatory activity in
permissive and nonpermissive cells (Klucher et al., 1993).
To observe the activity of gpUL37 in HFF cells, however,
it was necessary to cotransfect cells with expression
vectors of both gpUL37 and IE1. This requirement mayFIG. 8. The gpUL37 acidic domain mutant does not act synergistically
reflect cell-specific variables such as the level of gpUL37with pUS3. HeLa cells were transfected with pHB-CAT (10 mg) and with
DNA encoding pUS3 (5 mg) and the indicated DNAs (5 mg) or with expression in HFF cells or the availability of a necessary
vector DNA alone (5 mg). The average conversion of chloramphenicol cellular protein required for gpUL37 transactivation. IE1
to its acetylated forms was determined for each group as in Fig. 4. The could augment gpUL37 production via positive regulation
mean values for each group were determined using the results from
of the MIE promoter/enhancer (Cherrington et al., 1989).two experiments with duplicate samples each and were standardized
However, in the absence of IE1, we have observed abun-to values obtained in cells transfected with vector DNA alone.
dant expression of gpUL37 in transfected HFF cells. An-
other, more likely explanation is that IE1 induces the
control cells transfected with vector DNA alone (1.0 { expression of a cellular protein required for gpUL37
0.1-fold). The gpUL37 acidic domain mutant (Daa53-140) transactivation in HFF cells. Putatively, this cellular pro-
did not increase hsp70 expression synergistically in tein would be present in HeLa cells. It is also notable
presence of pUS3 (5.3 { 1.7-fold). This latter value was that the acidic domain mutant in presence of IE1 had
similar to those obtained with cells transfected with an more activity than wt gpUL37. This latter result suggests
expression clone of gB and pUS3 (4.4 { 1.7-fold) or with that the acidic domain in gpUL37 may be targeted for
cells transfected with vector and US3 DNA (6.2 { 2.4- negative regulation by IE1 or by a cellular product in-
fold). ANOVA showed that the acidic domain mutant had duced by IE1.
similar transactivating activity to that of the negative con- gpUL37 has a second measurable activity: synergism
trols, i.e., gB or the vector DNA (P 0.05). These results with pUS3 (Colberg-Poley et al., 1991, 1992; Tenney et
indicate that, in contrast with its nuclear regulatory activ- al., 1993). In contrast to transactivation, synergism with
ity, the gpUL37 acidic domain is required for its syner- pUS3 is adversely affected by deletion of its acidic do-
gism with pUS3. main. The loss of synergism is not likely to result from
the absence or aberrant location of the mutant protein.
The acidic domain mutant protein is active in transactiva-DISCUSSION
tion, is detected by IFA, and is indistinguishable from
the wt gpUL37 in abundance and location. Alternatively,We show herein that gpUL37 is a nonnuclear protein
and does not require its acidic domain for nuclear regula- requirement for the acidic domain may result if gpUL37
interacts through this domain directly with pUS3 or withtory activity or its localization. Loss of the gpUL37 acidic
domain, however, abolishes synergism with pUS3. Thus, a cellular protein necessary for synergism. Indeed, some
regulatory proteins are known to require bulky hydropho-the transactivating and synergistic activities of gpUL37
are genetically separable and map to different domains bic residues interspersed with acidic residues for pro-
tein:protein interactions and regulatory function (Tjianof the protein.
gpUL37 has an unusual structure for herpesvirus IE and Maniatis, 1994).
Conversely to our findings with IE1, gpUL37 is likelyproteins; that is, UL37 ORF encodes a type I membrane-
bound protein. Reactivity of Ab1601 with both the product to colocalize with pUS3. The US3 IE locus whose expres-
sion is controlled by positive and negative elements en-of the wt UL37 cDNA and with the acidic domain mutant
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codes a number of unspliced and spliced RNAs (Weston, minger, 1993) and to sequences upstream of the UL112
promoter (Artl et al., 1994).1988; Tenney et al., 1993; Rawlinson and Barrell, 1993;
Biegalke, 1995; Thrower et al., 1996). Similar to gpUL37, Rather than the more direct mechanisms of transacti-
vation listed above for IE1 and IE2, gpUL37 may transacti-the product of the unspliced US3 RNA is predicted to be
a type I membrane-bound protein (Weston, 1988). The vate nuclear gene expression indirectly by signaling. Sig-
naling results from diverse stimuli such as binding ofhydrophobic leader is encoded by all three major US3
RNAs. A single N-linked glycosylation site is found only extracellular ligands to cell surface receptors or by ion
movement through channels. Parenthetically, there is ain those species containing exon 3 sequences. Finally,
the TM/anchor sequence is encoded only by the un- precedent for a viral protein, the Influenza M2 integral
membrane protein, forming an ion channel (Pinto et al.,spliced US3 RNA. Cotransfection of expression vectors
encoding US3 proteins from the unspliced and the singly 1992). Signaling typically proceeds by the exquisitely or-
chestrated action of multiple cellular kinases and phos-spliced species regulates hsp70 promoter expression,
while the protein product of the doubly spliced species phatases (Hunter, 1995). Integral membrane proteins
lacking kinase domains can initiate signaling by bindingdoes not. Thus, the TM/anchor is not required for pUS3
transactivating activity (Tenney et al., 1993). to cellular kinases, such as JAK2 (Argetsinger et al.,
1993). In addition to signaling initiated at the cell surface,Repeated experiments in HeLa cells and in HFF cells
showed that the acidic domain mutant retains most of signaling can proceed intracytoplasmically from the ER
to the nucleus by the action of ERN1, a TM protein withthe wt regulatory activity. However, in one experiment,
the dose response titration, a significant decrease in the kinase activity (Mori et al., 1993). Inhibition of phospha-
tases also increases signaling pathways. SV40 small tregulatory activity of the mutant was observed. This find-
ing may have resulted from the use of different amounts antigen binds directly to protein phosphatase 2A subunit,
blocking its dephosphorylation of MEK, MEKK, and ERKof expression vector DNA transfected (2.5, 10 mg) in this
experiment or from the physiological state of the cells and, thereby, stimulating the Mitogen-Activated Protein
kinase pathway (Sontag et al., 1993).used for transfection. In independent experiments, we
have found that the state of cell confluency affects the If gpUL37 does not act by initiating signaling, other
more direct mechanisms may account for its regulatoryability of gpUL37 to transactivate nuclear gene expres-
sion (Zhang and Colberg-Poley, unpublished results). activity; for example, that of cleavage and translocation
of an active domain to the nucleus. The cytoplasmic re-Nevertheless, the acidic domain mutant still showed reg-
ulatory activity which is significantly above the negative ceptors for steroids translocate to the nucleus (Defranco
et al., 1995). Alternatively, vesicles containing membrane-control, vector. Taken together, these results suggest that
even though the acidic domain is not required for trans- bound gpUL37 could translocate from the ER or Golgi
apparatus to the nuclear membrane. However, usingactivation, its presence can affect regulatory function un-
der certain circumstances. confocal microscopy, Ab1601 did not detect the transacti-
vating protein in the nucleoplasm. If a translocated cleav-gpUL37 does not require the acidic domain for its nu-
clear regulatory activity. These results are in contrast age product of gpUL37 is responsible for nuclear trans-
activation then it predictably would not contain Ab1601with the requirement of several viral nuclear regulatory
proteins including the HCMV IE2 (Pizzorno et al., 1991), reactive sequences (aa473-487) unless minute amounts
of the cleavage product are sufficient to transactivateherpes simplex virus VP16 (Sadowski et al., 1988; Trie-
zenberg et al., 1988), and yeast Gal4 (Ma and Ptashne, nuclear gene expression. Our current studies are de-
signed to define further the domains involved in gpUL371987) proteins for their acidic domains. This difference
suggests that the mechanism of gpUL37 transactivation location, function, and its potential role in signaling.
is likely to be distinct from those of these nuclear regula-
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